posted on 2019-09-12, 18:35authored byYou-Sheng Cai, Cong Wang, Congkui Tian, Wen-Ting Sun, Ling Chen, Di Xiao, Si-Yuan Zhou, Guofu Qiu, Jianqing Yu, Kongkai Zhu, Sheng-Ping Yang
Two octahydro-protoberberine alkaloids,
alangiifoliumines A (<b>1</b>) and B (<b>2</b>), and two
new protoemetine derivatives,
alangiifoliumines C (<b>3</b>) and D (<b>4</b>), together
with 11 known compounds, have been isolated from the stems of <i>Alangium salviifolium</i>. While the structures of these compounds
were elucidated by spectroscopic methods, the absolute configurations
of the new alkaloids were determined by conformational analysis and
time-dependent density functional theory–electronic circular
dichroism spectra calculations on selected stereoisomers. Compounds <b>1</b> and <b>2</b> represent the first 5,8,8a,9,12,12a,13,13a-octahydro-protoberberine
derivatives, in which the aromatic ring D was reduced to cyclohexene.
All the compounds isolated were evaluated for their cytotoxic activity
against three human cancer cell lines: A-549, HeLa, and SKOV-3. Alkaloids <b>1</b>, <b>3</b>, and <b>6</b>–<b>14</b> exhibited inhibitory effects against all three human cancer cell
lines, with half-maximal inhibitory concentration (IC<sub>50</sub>) values in the range of 3 nM to 9.4 μM.